TY - JOUR
T1 - Association between circulating Galectin-3 and arterial stiffness in older adults
T2 - Atherosclerosis Risk in Communities (ARIC) Study
AU - Jia, Xiaoming
AU - Sun, Caroline
AU - Tanaka, Hirofumi
AU - Al Rifai, Mahmoud
AU - Aguilar, David
AU - Ndumele, Chiadi
AU - Selvin, Elizabeth
AU - Virani, Salim S.
AU - Hoogeveen, Ron C.
AU - Heiss, Gerardo
AU - Ballantyne, Christie M.
AU - Nambi, Vijay
N1 - Funding Information:
The Atherosclerosis Risk in Communities study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. (HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I).
Publisher Copyright:
© 2021 Hogrefe Verlag GmbH & Co. KG. All rights reserved.
PY - 2021/11
Y1 - 2021/11
N2 - Background: Galectin-3 (gal-3) is a β-galactoside-binding lectin associated tissue fibrosis and inflammation. There is limited understanding of the relationship between gal-3 and vascular health. Our aim was to assess the association between gal-3 and arterial stiffness in older adults. Methods: We conducted a cross-sectional study of 4275 participants (mean age of 75 years) from the Atherosclerosis Risk in Communities (ARIC) Study. Central arterial stiffness was measured by carotid-femoral pulse wave velocity (cfPWV). We evaluated the association of gal-3 with cfPWV using multivariable linear regression. Results: The median (interquartile range) gal-3 concentration was 16.5 (13.8, 19.8) ng/mL and mean cfPWV was 1163303 cm/s. Higher gal-3 concentration was associated with greater central arterial stiffness after adjustment for age, sex, race-center, heart rate, systolic blood pressure, anti-hypertensive medication use, and current smoking status (β=36.4 cm/s change in cfPWV per log unit change in gal-3; 95% CI: 7.2, 65.5, p=0.015). The association was attenuated after adjusting for additional cardiovascular risk factors (β=17.3, 95% CI: -14.4, 49.0). Conclusions: In community-dwelling older adults, gal-3 concentration was associated with central arterial stiffness, likely sharing common pathways with traditional cardiovascular risk factors.
AB - Background: Galectin-3 (gal-3) is a β-galactoside-binding lectin associated tissue fibrosis and inflammation. There is limited understanding of the relationship between gal-3 and vascular health. Our aim was to assess the association between gal-3 and arterial stiffness in older adults. Methods: We conducted a cross-sectional study of 4275 participants (mean age of 75 years) from the Atherosclerosis Risk in Communities (ARIC) Study. Central arterial stiffness was measured by carotid-femoral pulse wave velocity (cfPWV). We evaluated the association of gal-3 with cfPWV using multivariable linear regression. Results: The median (interquartile range) gal-3 concentration was 16.5 (13.8, 19.8) ng/mL and mean cfPWV was 1163303 cm/s. Higher gal-3 concentration was associated with greater central arterial stiffness after adjustment for age, sex, race-center, heart rate, systolic blood pressure, anti-hypertensive medication use, and current smoking status (β=36.4 cm/s change in cfPWV per log unit change in gal-3; 95% CI: 7.2, 65.5, p=0.015). The association was attenuated after adjusting for additional cardiovascular risk factors (β=17.3, 95% CI: -14.4, 49.0). Conclusions: In community-dwelling older adults, gal-3 concentration was associated with central arterial stiffness, likely sharing common pathways with traditional cardiovascular risk factors.
KW - Galectin-3
KW - aging
KW - arterial stiffness
UR - http://www.scopus.com/inward/record.url?scp=85112656783&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112656783&partnerID=8YFLogxK
U2 - 10.1024/0301-1526/a000968
DO - 10.1024/0301-1526/a000968
M3 - Article
C2 - 34346252
AN - SCOPUS:85112656783
SN - 0301-1526
VL - 50
SP - 439
EP - 445
JO - Vasa - European Journal of Vascular Medicine
JF - Vasa - European Journal of Vascular Medicine
IS - 6
ER -